We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CALL
Biogen
BIIB
$30.6B
| $35.2K | ﹤0.01% |
200
-2,000
| -91% | -$327K |
|
2777
CALL
American Tower
AMT
$78.8B
| $35.1K | ﹤0.01% |
+200
| New | +$36.4K |
|
2778
Protalix BioTherapeutics
PLX
$200M
| $34.3K | ﹤0.01% |
+19,079
| New | +$39K |
|
|
APLT
2779
DELISTED
Applied Therapeutics
APLT
| $33.7K | ﹤0.01% |
337,389
-2,205,299
| -87% | -$1.4M |
|
2780
CALL
General Dynamics
GD
$107B
| $33.7K | ﹤0.01% |
+100
| New | +$34.1K |
|
|
2781
PUT
General Dynamics
GD
$107B
| $33.7K | ﹤0.01% |
100
| – | – |
|
2782
CALL
Etsy
ETSY
$7.38B
| $33.3K | ﹤0.01% |
600
| – | – |
|
2783
PUT
Bank of America
BAC
$447B
| $33K | ﹤0.01% |
600
-1,800
| -75% | -$95.1K |
|
2784
CALL
Futu Holdings
FUTU
$15.2B
| $32.8K | ﹤0.01% |
200
-11,400
| -98% | -$1.96M |
|
2785
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
| $31.1K | ﹤0.01% |
400
-138,100
| -100% | -$10.8M |
|
2786
PUT
Dow Inc
DOW
$22.1B
| $30.4K | ﹤0.01% |
1,300
-1,200
| -48% | -$27.6K |
|
2787
Kosmos Energy
KOS
$1.49B
| $30.3K | ﹤0.01% |
33,272
-12,554
| -27% | -$16.5K |
|
2788
ALX Oncology
ALXO
$285M
| $29.8K | ﹤0.01% |
26,376
-13,207
| -33% | -$20K |
|
2789
PUT
Dollar General
DG
$27B
| $26.6K | ﹤0.01% |
200
+100
| +100% | +$11.2K |
|
2790
CALL
Gilead Sciences
GILD
$165B
| $24.5K | ﹤0.01% |
+200
| New | +$24.3K |
|
2791
CALL
Shake Shack
SHAK
$2.89B
| $24.4K | ﹤0.01% |
+300
| New | +$26.4K |
|
2792
CALL
Capital One
COF
$134B
| $24.2K | ﹤0.01% |
+100
| New | +$22.3K |
|
2793
PUT
iShares MSCI Turkey ETF
TUR
$217M
| $24.1K | ﹤0.01% |
+700
| New | +$23.7K |
|
2794
CALL
Sprouts Farmers Market
SFM
$7.96B
| $23.9K | ﹤0.01% |
+300
| New | +$26.9K |
|
|
2795
PUT
Sprouts Farmers Market
SFM
$7.96B
| $23.9K | ﹤0.01% |
300
-200
| -40% | -$17.9K |
|
2796
CALL
UiPath
PATH
$8.08B
| $22.9K | ﹤0.01% |
+1,400
| New | +$21.8K |
|
2797
PUT
DoorDash
DASH
$90.9B
| $22.6K | ﹤0.01% |
+100
| New | +$23.5K |
|
2798
CALL
Veeva Systems
VEEV
$38.1B
| $22.3K | ﹤0.01% |
100
| – | – |
|
2799
PUT
Lemonade
LMND
$4.08B
| $21.4K | ﹤0.01% |
+300
| New | +$20.2K |
|
2800
CALL
Teladoc Health
TDOC
$1.29B
| $21K | ﹤0.01% |
+3,000
| New | +$23.5K |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.